Liver cancer is a lethal disease with limited treatment options for advanced stages. While risk factors such as viral hepatitis, alcohol use, and obesity increase the likelihood of hepatocellular carcinoma (HCC, the progression of liver […]
Dogs share our homes, our habits and sometimes, our diseases. Gastric cancer is rare in dogs, but when it does strike, it closely resembles gastric cancer in humans: subtle clinical signs, comparable tumor subtypes, late-stage […]
A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn’t seen major drug advances in over a decade, researchers reported Monday.This article was […]
In the United States, approximately 55% of resected gallbladder cancer (GBC) patients undergo oncologic surgery without additional systemic treatment. However, as GBC progresses to the advanced tumor sizes T3 (locally or regionally advanced) or T4 […]
More and more thoracic CT scans are being performed worldwide in order to detect lung diseases such as bronchial carcinoma and tumor metastases at an early stage and allow them to be monitored. In Germany […]
The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad eligibility criteria, and reduced data collection, has quickly answered its primary question, finding that the investigational combination it tested […]
Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly […]
Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with standard chemotherapy before surgery had improved […]
Although immunotherapy is among the most significant advances in cancer care, it is not effective in all patients. University of Helsinki researchers have provided new insights into why some breast cancer treatments may not be […]
A study led by University of Cincinnati Cancer Center researchers sheds new light on the mechanisms by which a major oncogene promotes and sustains lymphoma development and progression, paving the way for novel targeted therapies.This […]
© 2025 SimplyWell.ca